ROBERT JOHN RIGLIETTI
Personal Electronic Health Record
DOCTOR DIRECTORY
Dr. Nika Harutyunyan
Internist
Status w/ Patient: ACTIVE
Gender: Female
Hospital Affiliations: Ronald Reagan UCLA Medical Center
Phone: (818) 461-8148
Email:
First Seen: 2026-06-02
Appointment Log
| Type | Date | Transcript |
|---|---|---|
Follow-Up | 2026-07-10 | |
New Patient | 2026-06-02 |
Tests
| Test Name | System | Date | Results | Result Notes | Other Notes | Medicine / Supplments | OG Report File | Facility | Lab Specimin No |
|---|---|---|---|---|---|---|---|---|---|
Blood Test | General | 2026-06-12 | Normal w/ Notes | Reviewed by Dr. Harutyunyan — "labs look ok for the most part." Notable findings: Vitamin D low at 16 ng/mL (inadequate range) — advised to start 1,000 IU Vitamin D3 daily; Vitamin B12 high at 1,824 pg/mL, consistent with ongoing methyl-B12 supplementation; HDL low at 38 mg/dL; fasting glucose mildly high at 101 mg/dL (A1c normal at 4.9%); MPV low at 8.3 fL (minor). TSH normal at 2.5 mcIU/mL (no reflex FT4/FT3 run). CMP, lipid panel, and CBC with differential otherwise within normal limits. COVID-19 nucleocapsid IgG antibody: Negative (resulted 2026-06-15). Dr. Harutyunyan noted UCLA's long-COVID program requires a positive nucleocapsid antibody for entry, so this negative result makes Rob ineligible there; she advised looking into the Henry Mayo long-COVID program instead. Drawn 2026-06-12 at UCLA Outreach Clinical Lab (Panorama City), ordered at the 2026-06-02 establish-care visit. | Duloxetine | 20 mg (2024),Vitamin D3 | 2000 IUs (2024),Magnesium Malate | 113 mg (Elemental) (2025),Riboflavin-5-Phosphate | 50 mg (2026),Methyl B12 | 5000 mcg (2026),Pyridoxal-5-Phosphate | 8.5 mg (2026) | UCLA |
